Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach

Int J Cardiol. 2008 Aug 1;128(1):91-3; author reply 94-6. doi: 10.1016/j.ijcard.2008.01.034. Epub 2008 May 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use*
  • Dobutamine / administration & dosage
  • Dobutamine / therapeutic use
  • Heart Failure / blood
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Humans
  • Hydrazones / administration & dosage
  • Hydrazones / therapeutic use*
  • Infusions, Intravenous
  • Natriuretic Peptide, Brain / blood
  • Predictive Value of Tests
  • Prognosis
  • Pyridazines / administration & dosage
  • Pyridazines / therapeutic use*
  • Simendan
  • Time Factors

Substances

  • Adrenergic beta-Antagonists
  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Natriuretic Peptide, Brain
  • Simendan
  • Dobutamine